Trial · NCT02533375
Adverse events49
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 49
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Eosinophilia | Blood and lymphatic system disorders | Participants Receiving Adalimumab | 1 | 10 | |
| other | Cardiac failure | Cardiac disorders | Participants Receiving Adalimumab | 1 | 10 | |
| other | Autoimmune Thyroiditis | Endocrine disorders | Participants Receiving Adalimumab | 1 | 10 | |
| other | Dry eye | Eye disorders | Participants Receiving Adalimumab | 1 | 10 | |
| other | Episcleritis | Eye disorders | Participants Receiving Adalimumab | 1 | 10 | |
| other | Glaucoma | Eye disorders | Participants Receiving Adalimumab | 1 | 10 | |
| other | Abdominal pain | Gastrointestinal disorders | Participants Receiving Adalimumab | 1 | 10 | |
| other | Oedema | General disorders | Participants Receiving Adalimumab | 1 | 10 | |
| other | Oedema peripheral | General disorders | Participants Receiving Adalimumab | 1 | 10 | |
| other | Pyrexia | General disorders | Participants Receiving Adalimumab | 1 | 10 | |
| other | Hepatic Function Abnormal | Hepatobiliary disorders | Participants Receiving Adalimumab | 1 | 10 | |
| other | Hepatic Steatosis | Hepatobiliary disorders | Participants Receiving Adalimumab | 1 | 10 | |
| other | Liver disorder | Hepatobiliary disorders | Participants Receiving Adalimumab | 1 | 10 | |
| other | Bacterial infection | Infections and infestations | Participants Receiving Adalimumab | 1 | 10 | |
| other | Body tinea | Infections and infestations | Participants Receiving Adalimumab | 1 | 10 | |
| other | Cellulitis | Infections and infestations | Participants Receiving Adalimumab | 1 | 10 | |
| other | Chronic sinusitis | Infections and infestations | Participants Receiving Adalimumab | 1 | 10 | |
| other | Enterocolitis bacterial | Infections and infestations | Participants Receiving Adalimumab | 1 | 10 | |
| other | Enterocolitis infectious | Infections and infestations | Participants Receiving Adalimumab | 1 | 10 | |
| other | Folliculitis | Infections and infestations | Participants Receiving Adalimumab | 1 | 10 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02533375/events